Stay updated on Nivolumab Neoadjuvant Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.

Latest updates to the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page
- Check7 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference1%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.8%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has undergone significant content removal regarding a study on neoadjuvant treatment for high-risk HPV-driven oropharynx cancer, including detailed methodology and inclusion/exclusion criteria. The only notable addition is the mention of the EudraCT number and a revision update.SummaryDifference34%
Stay in the know with updates to Nivolumab Neoadjuvant Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.